| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6253313 | Journal of Surgical Research | 2016 | 7 Pages |
Abstract
Non-weight-based enoxaparin dosing did not achieve target anti-FXaA levels in most TP. Higher anti-FXaA levels correlated with larger weight-based enoxaparin doses. Weight-based enoxaparin dosing (i.e., 0.5Â mg/kg subcutaneously every 12Â h) would better achieve target anti-FXaA levels.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Scott A. PharmD, Eric D. MD, Patty RN, Gregory J. MD,